1. Home
  2. NXTC vs MTEK Comparison

NXTC vs MTEK Comparison

Compare NXTC & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXTC
  • MTEK
  • Stock Information
  • Founded
  • NXTC 2015
  • MTEK 2008
  • Country
  • NXTC United States
  • MTEK Israel
  • Employees
  • NXTC N/A
  • MTEK N/A
  • Industry
  • NXTC Biotechnology: Pharmaceutical Preparations
  • MTEK
  • Sector
  • NXTC Health Care
  • MTEK
  • Exchange
  • NXTC Nasdaq
  • MTEK Nasdaq
  • Market Cap
  • NXTC 21.6M
  • MTEK 21.7M
  • IPO Year
  • NXTC 2019
  • MTEK 2022
  • Fundamental
  • Price
  • NXTC $0.72
  • MTEK $2.58
  • Analyst Decision
  • NXTC Strong Buy
  • MTEK
  • Analyst Count
  • NXTC 2
  • MTEK 0
  • Target Price
  • NXTC $4.00
  • MTEK N/A
  • AVG Volume (30 Days)
  • NXTC 61.8K
  • MTEK 82.8K
  • Earning Date
  • NXTC 03-20-2025
  • MTEK 03-20-2025
  • Dividend Yield
  • NXTC N/A
  • MTEK N/A
  • EPS Growth
  • NXTC N/A
  • MTEK N/A
  • EPS
  • NXTC N/A
  • MTEK N/A
  • Revenue
  • NXTC N/A
  • MTEK $6,967,508.00
  • Revenue This Year
  • NXTC N/A
  • MTEK N/A
  • Revenue Next Year
  • NXTC N/A
  • MTEK N/A
  • P/E Ratio
  • NXTC N/A
  • MTEK N/A
  • Revenue Growth
  • NXTC N/A
  • MTEK 246.50
  • 52 Week Low
  • NXTC $0.66
  • MTEK $1.13
  • 52 Week High
  • NXTC $2.57
  • MTEK $6.47
  • Technical
  • Relative Strength Index (RSI)
  • NXTC 40.34
  • MTEK 38.10
  • Support Level
  • NXTC $0.66
  • MTEK $2.82
  • Resistance Level
  • NXTC $0.79
  • MTEK $2.86
  • Average True Range (ATR)
  • NXTC 0.06
  • MTEK 0.29
  • MACD
  • NXTC 0.00
  • MTEK -0.01
  • Stochastic Oscillator
  • NXTC 42.21
  • MTEK 14.82

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

Share on Social Networks: